Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ocular Therapeutix, Inc.(OCUL) | 2,635,287 | 2,771,130 | +135,843 | $23.98M | $18.95M | 15.98% | -$5.03M |
| Enliven Therapeutics Inc | 396,099 | 397,698 | +1,599 | $6.97M | $9.29M | 7.83% | +$2.33M |
| Vaxcyte, Inc.(PCVX) | 104,830 | 110,400 | +5,570 | $7.16M | $8.34M | 7.03% | +$1.18M |
| Dyne Therapeutics, Inc.(DYN) | 184,500 | 212,500 | +28,000 | $5.24M | $7.50M | 6.32% | +$2.26M |
| Praxis Precision Medicines, Inc.(PRAX) | 162,302 | 164,431 | +2,129 | $9.90M | $6.80M | 5.73% | -$3.10M |
| Crinetics Pharmaceuticals | 78,403 | 135,141 | +56,738 | $3.67M | $6.05M | 5.10% | +$2.38M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 326,787 | 250,370 | -76,417 | $8.80M | $5.39M | 4.54% | -$3.41M |
| Taysha Gene Therapies, Inc.(TSHA) | 3,333,333 | 2,330,937 | -1,002,396 | $9.57M | $5.22M | 4.40% | -$4.35M |
| Revolution Medicines, Inc.(RVMD) | 143,777 | 133,000 | -10,777 | $4.63M | $5.16M | 4.35% | +$527.8K |
| Insmed Incorporated(INSM) | 61,718 | 72,100 | +10,382 | $1.67M | $4.83M | 4.07% | +$3.16M |
| Sarepta Therapeutics, Inc.(SRPT) | 64,162 | 27,500 | -36,662 | $8.31M | $4.34M | 3.66% | -$3.96M |
| Tourmaline Bio Inc | 261,108 | 269,614 | +8,506 | $5.98M | $3.47M | 2.92% | -$2.51M |
| Agios Pharmaceuticals, Inc.(AGIO) | 55,262 | 78,700 | +23,438 | $1.62M | $3.39M | 2.86% | +$1.78M |
| Kura Oncology, Inc.(KURA) | 90,000 | 163,000 | +73,000 | $1.92M | $3.36M | 2.83% | +$1.44M |
| Mersana Therapeutics Inc | 2,164,628 | 1,663,000 | -501,628 | $9.70M | $3.34M | 2.82% | -$6.35M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 0 | 64,500 | +64,500 | $0 | $2.92M | 2.46% | +$2.92M |
| Whitehawk Therapeutics, Inc.(WHWK) | 1,849,402 | 1,849,402 | 0 | $4.33M | $2.70M | 2.28% | -$1.63M |
| Viridian Therapeutics, Inc.(VRDN) | 199,433 | 199,433 | 0 | $3.49M | $2.59M | 2.19% | -$897.4K |
| Terns Pharmaceuticals Inc | 465,079 | 369,280 | -95,799 | $3.05M | $2.51M | 2.12% | -$536.1K |
| Mereo BioPharma Group plcADS(MREO) | 397,884 | 677,000 | +279,116 | $1.31M | $2.44M | 2.05% | +$1.12M |
| Arcellx Inc COMMON STOCK | 34,500 | 42,200 | +7,700 | $2.40M | $2.33M | 1.96% | -$70.5K |
| Helix Acquisition Corp IiCL A | 0 | 177,836 | +177,836 | $0 | $1.82M | 1.53% | +$1.82M |
| argenx SEADR(ARGX) | 0 | 4,000 | +4,000 | $0 | $1.72M | 1.45% | +$1.72M |
| Trevi Therapeutics, Inc.(TRVI) | 0 | 260,000 | +260,000 | $0 | $774.8K | 0.65% | +$774.8K |
| Celcuity Inc.(CELC) | 0 | 45,000 | +45,000 | $0 | $737.1K | 0.62% | +$737.1K |
| ORIC Pharmaceuticals, Inc.(ORIC) | 103,992 | 96,000 | -7,992 | $1.43M | $678.7K | 0.57% | -$751.2K |
| Pliant Therapeutics, Inc.(PLRX) | 0 | 46,200 | +46,200 | $0 | $496.6K | 0.42% | +$496.6K |
| Rapport Therapeutics, Inc.(RAPP) | 0 | 20,000 | +20,000 | $0 | $465.2K | 0.39% | +$465.2K |
| Newamsterdam Pharma Co Nv ORDINARY SHARES | 0 | 22,500 | +22,500 | $0 | $432.2K | 0.36% | +$432.2K |
| Cypherpunk Technologies Inc.(CYPH) | 354,166 | 195,000 | -159,166 | $942.1K | $382.2K | 0.32% | -$559.9K |
| Cellectar Biosciences, Inc.(CLRB) | 143,500 | 70,500 | -73,000 | $571.1K | $176.3K | 0.15% | -$394.9K |
| Nuvation Bio Inc.W EXP 07 07 2027(NUVB) | 90,832 | 90,832 | 0 | $27.5K | $14.5K | 0.01% | -$12.9K |
| Applied Therapeutics Inc | 792,000 | 0 | -792,000 | $5.39M | $0 | — | -$5.39M |
| Celldex Therapeutics, Inc.(CLDX) | 109,000 | 0 | -109,000 | $4.57M | $0 | — | -$4.57M |
| Disc Medicine, Inc.(IRON) | 76,800 | 0 | -76,800 | $4.78M | $0 | — | -$4.78M |
| Hillevax Inc | 250,609 | 0 | -250,609 | $4.17M | $0 | — | -$4.17M |
| Immunovant, Inc.(IMVT) | 92,346 | 0 | -92,346 | $2.98M | $0 | — | -$2.98M |
| Intra-Cellular Therapies Inc. | 13,300 | 0 | -13,300 | $920.4K | $0 | — | -$920.4K |
| Lyra Therapeutics Inc | 173,320 | 0 | -173,320 | $1.08M | $0 | — | -$1.08M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 20,000 | 0 | -20,000 | $933.8K | $0 | — | -$933.8K |
| Verastem, Inc.(VSTM) | 207,095 | 0 | -207,095 | $2.44M | $0 | — | -$2.44M |